Can tracking ambulance ventilators improve emergency breathing care?
NCT ID NCT05604430
First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time
Summary
This study tracks how paramedics use the ZOLL 731 ventilator when helping people with serious conditions like cardiac arrest, sepsis, or heart failure before they reach the hospital. Researchers will record which ventilator modes and settings are used, and how often alarms go off. The goal is to understand real-world ventilator use in ambulances, which could guide better training and emergency care protocols.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ZOLL 731 Series ventilator
- What this could lead to
- If this works, it could lead to better training and protocols for emergency ventilation, improving care for patients with breathing or heart emergencies.
- What could go wrong
- This is an observational study, so it won't test a new treatment. The findings may not change practice, and ventilator use can vary widely between emergency teams.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2022
- Expected to finish
-
Apr 2030
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Cases where participating EMS Agencies use ZOLL 731 Series ventilator in accordance with device labeling and Agency protocols in a pre-hospital setting
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Candidates for this study must meet all of the following Inclusion criteria: 1. Ventilated using ZOLL 731 Series ventilator with Release 5 (or greater) software 2. Data recorded in ventilator data file Exclusion Criteria: * None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Altered mental status are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
5 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Aetna Ambulance Service, Inc
Hartford, Connecticut, 06106, United States
-
East Baton Rouge EMS
Baton Rouge, Louisiana, 70807, United States
-
Gig Harbor Fire Department
Rosedale, Washington, 98332, United States
-
MedStar
Fort Worth, Texas, 76116, United States
-
Uxbridge Fire
Uxbridge, Massachusetts, 01569, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Persistent inflammation, immunosuppression and catabolism syndrome (PICS): a new horizon for surgical critical care subtitle: cardiac dysfunction in older sepsis survivors subtitle: development of a designer Proline-Rich antimicrobial peptide chaperone protein inhibitor (DPC) for treating sepsis
- A randomized clinical trial of early empiric Anti-Mycobacterium tuberculosis therapy for sepsis in Sub-Saharan africa
- Tracing of real-time glu13Cose metabolism in human immune cells - intensive care unit
- The impact of video-based cardiac rehabilitation education in patients with cardiovascular implantable electronic Devices(CIEDs)- a randomized controlled trial
- Mean arterial pressure after out-of-hospital cardiac arrest: the METAPHORE randomized trial
- Effect of the use of dapagliflozin in diuresis, natriuresis and in ultrafiltration and peritoneal elimination of sodium, in patients with refractory heart failure